The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
USA up 10.53% so far
Looks like the tradable Option is the one to buy and the share to sell...at the moment
ASX: MXCOE
https://www.intelligentinvestor.com.au/shares/asx-mxcoe/option-expiring-31-aug-2021
End of Q2? Dread to think what the SP will be then with these daily drops.
And before anyone starts saying about straight lines, just note it also works the other way around, i.e. down as well as up.
Pokerchips mate.
I'm hoping they send some good numbers out for Q1 as they received some money from SPC in February. I believe we are in the right direction and as you mention in Q2 we should get the proper number.
Oh and don't forget this is just for the one product, Rescue, there are the other 2 products yet to be ordered, Support and Prevention. We have no idea what kind of revenue stream these products will bring in as yet.
Some of the order is aimed at ONASIS Holding Corp (OTC: ONSS) as a master distributor in the USA and Central America under the exclusive distribution agreement
MXC are selling MGC Nutraceuticals for US$6m worth of shares in Onasis Holdings Corp, which is currently expected to be completed in H1 2021, subject to completion of a capital raising and US regulatory approvals
So these are all linked together in some way
Ehsan
Correct ..Q1 figures will still show negative cash flows...it is Q2 when things should really start to improve ..given the aim of cash outflow balance by end of Q2
It doesn't actually say when these orders will be delivered to Swiss Pharmacan AG ...so one has to assume everything is waiting for the "regulatory submissions" to be put in and dealt with....
I am guessing that they are going to book these orders as "contracted but unrecognised revenue" or such like ..until the income gets actually paid further down the line ?
@sunnyca
I read the RNS one more time and you are correct on that.
Thanks for bringing that up.
I guess we just need to wait for the first quarter number to come this month and see what they are doing.
sunnyca
My personal view is that this latest news isnt new....in my opinion they have known it since they did the Glow deal back in February...
They have just announced it now though..Glow had a fund raise too
"Glow and Swiss PharmaCan are now preparing regulatory submissions to pave the way for North American commercialization as a food supplement, or equivalent, in each of the relevant jurisdictions."
The question is ..
How long are all the "regulatory submissions" going to take before they start to actually start commercially selling it ?
Hi Eshan, this is where people are missing the point :- The revised order is now for 85% more units initially which gives them 18500 units not 10,000 as initially requested, this gives them (SPC) a revised expected sales figure of $1,572,500 for those units. The worth to us MXC is $425,000 in revenue from the increased orde ror 275,000 Euros for the 18500 units, which gives a unit price of 15 Euros. Simple, but we had no idea before today the cost of each unit. It's been less than 2 weeks and the initial order has virtually doubled which tells me they have virtually doubled the potential customer base already.
Hi sunnyca,
I know for sure the MGC can supply 40000 units per month right now. ( from Slovenia )
So based on that they are able to supply 480,000 units per year.
The first order from swiss pharma in February was for 10000 units for $850.000 plus this new order for $425,000.
Would you tell me if you think the company giving us the number in RNS actually is not for them ( $850.000 and $425.000 )
and also how did you get to 15 Euros each unites?
I'm getting confused now.
Thank mate
ignore all the noise is my advice to any investor, especially from the "extreme" camps who usually have very little experience, go with your research etc. This company will be successful and sooner than most think as the numbers sink in after todays RNS, by numbers I don't mean the increase in the initial order but the valuation they gave to the order itself for MGC, this was missing from the first one regarding the SPC contract, it only gave the worth to SwissPharma (850,000) now we have a figure for each unit in revenue to MGC, I suspect most who read the RNS this morning missed the significance of this or missed it completely as I've been able to add at silly levels and will continue to do so. 15 Euros each if anyone is interested. You can extrapolate from there with orders already placed (tiny initially) but 160,000 units a year is probably >1% of what they'll end up moving worldwide in the first year.